Phillip J. Platt - Mar 2, 2023 Form 4 Insider Report for Ingevity Corp (NGVT)

Signature
Phillip J. Platt By: Mavis Huger as Attorney-in-Fact
Stock symbol
NGVT
Transactions as of
Mar 2, 2023
Transactions value $
-$488,546
Form type
4
Date filed
3/6/2023, 06:30 PM
Previous filing
Mar 1, 2023
Next filing
Jul 26, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NGVT Common Stock Options Exercise $63.8K +2.29K +26.85% $27.90 10.8K Mar 2, 2023 Direct
transaction NGVT Common Stock Sale -$187K -2.29K -21.16% $81.70 8.52K Mar 2, 2023 Direct F1
transaction NGVT Common Stock Options Exercise $64.1K +1.21K +14.16% $53.11 9.73K Mar 2, 2023 Direct
transaction NGVT Common Stock Sale -$98.5K -1.21K -12.4% $81.63 8.52K Mar 2, 2023 Direct F2
transaction NGVT Common Stock Options Exercise $106K +2.36K +27.72% $45.04 10.9K Mar 2, 2023 Direct
transaction NGVT Common Stock Sale -$193K -2.36K -21.71% $81.62 8.52K Mar 2, 2023 Direct F3
transaction NGVT Common Stock Sale -$245K -2.99K -35.07% $81.83 5.53K Mar 2, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NGVT Employee Stock Option (right to buy) Options Exercise $0 -2.29K -100% $0.00* 0 Mar 2, 2023 Common Stock 2.29K $27.90 Direct F4
transaction NGVT Employee Stock Option (right to buy) Options Exercise $0 -1.21K -100% $0.00* 0 Mar 2, 2023 Common Stock 1.21K $53.11 Direct F5
transaction NGVT Employee Stock Option (right to buy) Options Exercise $0 -2.36K -100% $0.00* 0 Mar 2, 2023 Common Stock 2.36K $45.04 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.64 to $81.73, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.60 to $81.65, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.60 to $81.69, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 The option, representing a right to purchase a total of 2,288 shares, became fully vested and exercisable on February 27, 2019.
F5 The option, representing a right to purchase a total of 1,207 shares, became fully vested and exercisable on February 27, 2020.
F6 The option, representing a right to purchase a total of 2,363 shares, became fully vested and exercisable on February 28, 2023.